CAS Registry Number is one of those subjects where the details matter more than the headlines. This page pulls together the background, the mechanisms, and the practical points readers ask about most.
Updated 2026-01-20. Numbers and descriptions here follow the published literature rather than marketing material.
Purity and identity are usually assessed with reverse-phase high-performance liquid chromatography (RP-HPLC) and mass spectrometry. RP-HPLC separates components by hydrophobicity and can estimate peptide purity. Mass spectrometry confirms molecular mass and helps detect truncations or modifications. Some laboratories also use amino acid analysis or nuclear magnetic resonance for structural verification. A certificate of analysis from a supplier may list these results, but independent verification is often recommended for critical work.
Regulatory status varies by country, and dihexa is not widely approved as a medicine. In many jurisdictions it is treated as a research chemical, which limits its legal sale, possession, and human use. Products marketed online may lack verified purity or identity, and labels can be inaccurate. Researchers typically source material from suppliers that provide analytical documentation and follow institutional safety rules. Open questions remain about long-term stability, metabolite formation, and human pharmacokinetics.
Dihexa is typically supplied as a lyophilized powder for laboratory research. Lyophilization removes water and improves stability during transport and storage. The solid is commonly stored at -20 °C or lower, desiccated, and protected from light. Repeated freeze-thaw cycles and exposure to moisture can degrade peptides, so aliquoting and sealed containers are standard practice in most laboratory settings. These handling measures apply to research-grade material and do not imply clinical suitability.
Dihexa appears in scientific literature, patent documents, and commercial catalogs under several names, which can complicate searching and verification. The compound is frequently grouped with nootropics or research chemicals, terms that describe context of use rather than regulatory approval. Such labeling may imply benefits that have not been confirmed in controlled human studies. Readers encountering promotional descriptions should distinguish between preclinical observations and established medical facts. The absence of regulatory approval is a central feature of its current status.
Dihexa is a synthetic peptide-like compound studied in preclinical research for its reported effects on synaptic growth and cognitive measures in animal models. It is often described as an analog of angiotensin IV, a naturally occurring peptide fragment. The compound has not been approved as a medicine in any major jurisdiction. Most public information comes from laboratory studies, patents, and online vendor listings rather than from large clinical trials. Its scientific status therefore differs from that of an established pharmaceutical.
| Property | Value | Notes |
|---|---|---|
| Appearance | White to off-white powder | Typical lyophilized research form. |
| Solubility | Soluble in DMSO; limited in water | Depends on purity and salt form. |
| Storage temperature | -20 °C or lower | Desiccated and protected from light. |
| Analytical method | RP-HPLC and LC-MS | Common for purity and identity. |
| Regulatory status | Research chemical in many countries | Not widely approved as a medicine. |
Regulatory treatment varies by country. Dihexa does not appear in major pharmacopeias as a licensed therapeutic substance. Suppliers may use labels such as research use only or not for human consumption. Such labels reflect legal and quality-control boundaries rather than evidence of clinical benefit. Importation, possession, and sale can be restricted depending on local laws, and enforcement focuses on claims, distribution channels, and product categories. These rules can change, and they differ from rules for approved medicines.
Dihexa is a synthetic peptide studied in preclinical neuroscience. It is often described as an angiotensin IV analog or derivative. The compound also appears under research codes such as PNB-0408 and N-hexanoic-Tyr-Ile-(6)-aminohexanoic amide. It is not an approved drug, and it is not a conventional vitamin or nutrient. In many jurisdictions, material sold as dihexa is handled as a research chemical rather than a medicine or supplement. This classification affects how the material is labeled and distributed.
The full name often given is N-hexanoic-Tyr-Ile-(6)-aminohexanoic amide. This name indicates a chain containing tyrosine, isoleucine, and a six-carbon amino acid derivative. Databases list a CAS Registry Number and a molecular formula for the compound. The peptide is small compared with proteins, and its structure allows it to be studied in cell cultures and animal models. Exact identity depends on the supplier's synthesis and purification process. Minor impurities can remain after synthesis.
Chemically, dihexa belongs to a broader group of angiotensin IV analogs. Researchers have modified the natural peptide to alter stability, binding, or distribution. Such changes can affect how the molecule behaves in experiments. The parent peptide angiotensin IV is involved in various physiological processes, but the modified analog is not identical to it. Public summaries sometimes blur the distinction between the natural fragment and the synthetic research compound. This distinction matters when interpreting study results.
Dihexa is a synthetic peptide that has been examined in laboratory and animal research. Its design is based on angiotensin IV, a naturally occurring peptide fragment produced in the body. The short name dihexa appears in scientific papers and online discussions, while the full chemical name describes a modified peptide chain. It is not a vitamin, mineral, or plant-derived compound. Suppliers typically present it as a research chemical rather than an approved medicine.
The proposed mechanism of dihexa involves activation of hepatocyte growth factor and its receptor, c-Met. In cell models, this signaling pathway is associated with dendritic spine formation and synaptic reorganization. Dihexa is described as a stabilized analog of angiotensin IV, which also interacts with related systems. However, the precise binding profile and downstream effects remain incompletely characterized. Most mechanistic evidence comes from in vitro assays and rodent studies rather than human trials.
Laboratory characterization of dihexa typically relies on reverse-phase high-performance liquid chromatography for purity and mass spectrometry for identity. These methods are standard for synthetic peptides and help distinguish the target compound from related impurities or degradation products. Because dihexa is a small peptide-like molecule, it may be susceptible to hydrolysis under certain conditions. Storage recommendations generally emphasize low temperature, dryness, and protection from light. Analytical certificates from suppliers vary in detail, so independent verification can be important for research use.
The leading hypothesis for dihexa centers on hepatocyte growth factor (HGF) and its receptor, c-Met. In cell-based assays, dihexa has been reported to potentiate HGF-dependent signaling. That pathway influences cell growth, survival, and motility. Because c-Met signaling is widespread, the proposed mechanism is broad rather than specific to neurons. The exact binding site and stoichiometry remain areas of active investigation, and independent replication is limited. This uncertainty limits firm conclusions about how the compound acts in living organisms.
Animal studies have examined dihexa in models of cognitive impairment, synaptic plasticity, and memory. Some reports describe improved performance on maze or avoidance tasks after administration. These findings are preclinical and often involve small samples, varied routes, and differing formulations. Results in rodents do not establish effects in humans. The absence of published randomized controlled trials in people is a major gap in the evidence base. Observational reports and user accounts do not substitute for controlled clinical data.
Discussion in the literature often separates direct receptor activation from downstream growth-factor modulation. Dihexa is not simply an angiotensin receptor blocker or a classic nootropic drug. Its proposed action may depend on endogenous HGF levels, which vary by tissue and physiological state. Questions remain about brain penetration, metabolic stability, and active metabolites. Reviews note that mechanistic claims should be treated as hypotheses until supported by independent studies. That distinction is important when interpreting promotional claims or early laboratory findings.
=== Pre-release === On April 12, 2000, Valve Software announced a partnership with the Counter-Strike Team, confirming that Counter-Strike 1.0 would be included in an upcoming Half-Life patch. Though not explicitly stated, it is widely believed that this followed Valve's acquisition of Counter-Strike. Statements suggest the rights were sold in early 2000, involving a financial transaction. Despite the partnership, two more beta versions were released. Beta 6.5 (June 8, 2000) introduced an updated netcode, while Beta 7.0 (August 26, 2000) added drive-able vehicles. Following the acquisition of the game by Valve, while Cliffe continued working for them, Le did additional work towards a Counter-Strike 2.0 based on Valve's upcoming Source engine, but left to start his own studio after Valve opted to shelve the sequel. Valve planned to release Counter-Strike both as a Half-Life mod and a standalone retail product on August 31, 2000. The decision aimed to increase accessibility and test market demand for a multiplayer game independent of Half-Life. Legal issues arose before the retail release, particularly regarding weapon names, which were changed to fictional alternatives. Valve also had to secure rights for maps and textures, leading to modifications and removals of certain assets. Minh Le, one of the original developers, compensated mappers whose work Valve did not purchase.
===== Methane ===== Methane produced by marine methanogens is typically more D-enriched than methane produced by methanogens grown in freshwater. δDs for thermogenic methane range from −275‰ to −100‰, and from −400‰ to −150‰ for microbial methane.
The reasons for the strikes called by the illegal Workers' Commissions were fundamentally economic ─ the seriousness of the "1973 oil crisis" was accentuated ─ but they also had political motivations since the demands for wage increases or improvements in working conditions were accompanied by others such as freedom of union, the recognition of the right to strike, freedom of assembly and association, when not directly demanding amnesty for political prisoners and exiles. The government's response was repression. On March 3, 1976, the most serious incidents took place in Vitoria, which resulted in the death of five people by police gunfire. A general strike was immediately declared in the Basque Country and Navarre in solidarity with the victims, which had a huge following ─ also in other areas. For much of the opposition, the "Vitoria massacre" showed the true face of the "Arias-Fraga reform" and demonstrations and strikes intensified, with subsequent clashes with the forces of law and order ─ in Basauri, near Bilbao, another worker died shortly afterwards. In spite of everything, the mobilizations did not have a sufficient following to overthrow the government, much less the "Francoist monarchy".
The chain of reactions that generate reactive oxygen species (ROS) results in oxidative stress, which ultimately causes cell damage. Type II pathway of photodynamic reaction: After PS is excited into T1 state, the energy is transferred directly between PS and O2. This interaction transforms the oxygen molecules into a highly reactive form known as singlet oxygen. Singlet oxygen possesses potent oxidizing properties, making it extremely effective in reacting with and damaging cellular components. However, this reaction is selective; while most cellular components exist in a less reactive singlet state and remain unaffected, the singlet oxygen specifically targets and reacts with oxygen molecules in the cell cytoplasm. PDT is used to treat cancer across diverse types and sites. A unique feature of PDT is that photosensitizers tend to accumulate more selectively in cancer cells than in normal cells. The high affinity of photosensitizers to low-density lipoprotein (LDL) allows for selectivity. LDL acts as a carrier, allowing photosensitizers to travel into cancerous tissues. The interaction between photosensitizers and LDL makes it easier for therapeutic agents to reach the right places, which makes PDT more effective against cancer.
On 1 July, a WHO official said a ban on public gatherings remained, and people were required to wear masks in public. KCNA and Rodong Sinmun released images from a meeting on 2 July with Kim Jong Un and dozens of officials, none of whom were shown wearing masks. According to Dr. Edwin Salvador, the WHO's representative in North Korea, 922 people in the country were tested for COVID-19 and all had tested negative. On 25 July, Kim Jong Un attended an emergency meeting after a suspected COVID-19 case was reported in the city of Kaesong. Kim declared a state of emergency and imposed a lockdown on the city. The suspected case was reported to be an individual who had defected to South Korea three years earlier, before swimming back to North Korea in July (a rare case of "re-defection"). According to a South Korean senior health official, the individual was neither registered as a COVID-19 patient, nor classified as someone who came in contact with other patients. Two close contacts of the defector in South Korea tested negative for the virus. On 5 August, Salvador said the returning defector was tested but the "results were inconclusive". On 14 August, the three week lockdown in Kaesong and nearby areas was lifted by Kim Jong Un, after "the scientific verification and guarantee by a professional anti-epidemic organisation". According to South Korean intelligence, in August a North Korean official was executed for violating COVID-19 restrictions by bringing goods to Sinuiju from across the Chinese border.
Sources: en.wikipedia.org
=== Winemaking === The content of glutathione in must, the first raw form of wine, determines the browning, or caramelizing effect, during the production of white wine by trapping the caffeoyltartaric acid quinones generated by enzymic oxidation as grape reaction product. Its concentration in wine can be determined by UPLC-MRM mass spectrometry.
The university's dental hospital moved to the Huaxiba campus in 1928 and became the Stomatological Hospital of West China Union University. During the 1930s and 1940s, the institution expanded its research and academic activities. A medical and dental research section was established in 1936, followed by a dedicated oral-disease research section in the 1940s.
=== Ion mobility spectrometry === Explosive detection using ion mobility spectrometry (IMS) is based on velocities of ions in a uniform electric field. There are some variant to IMS such as Ion trap mobility spectrometry (ITMS) or Non-linear dependence on ion mobility (NLDM) which are based on IMS principle. The sensitivity of devices using this technology is limited to pg levels. The technology also requires the ionization of sample explosives which is accomplished by a radioactive source such as nickel-63 or americium-241. This technology is found in most commercially available explosive detectors such as the GE VaporTracer, Smith Sabre 4000 and Russian built MO-2M and MO-8. The presence of radioactive materials in these equipments cause regulatory hassles and requires special permissions at customs ports. These detectors cannot be field serviced and may pose radiation hazard to the operator if the casing of the detector cracks due to mishandling. Bi-yearly checks are mandatory on such equipment in most countries by regulating agencies to ensure that there are no radiation leaks. Disposal of these equipments is also controlled owing to the high half-life of the radioactive material used. Electrospray ionization, mobility analysis (DMA) and tandem mass spectrometry (MS/MS) is used by SEDET (Sociedad Europea de Detección) for the “Air Cargo Explosive Screener (ACES)”, targeted to aviation cargo containers currently under development in Spain.
Modern units use a magnetic door gasket that holds the door sealed but allows it to be pushed open from the inside. This gasket was invented, developed and manufactured by Max Baermann (1903–1984) of Bergisch Gladbach/Germany. Regarding total life-cycle costs, many governments offer incentives to encourage recycling of old refrigerators. One example is the Phoenix refrigerator program launched in Australia. This government incentive picked up old refrigerators, paying their owners for "donating" the refrigerator. The refrigerator was then refurbished, with new door seals, a thorough cleaning, and the removal of items such as the cover that is strapped to the back of many older units. The resulting refrigerators, now over 10% more efficient, were then given to low-income families. The United States also has a program for collecting and replacing older, less-efficient refrigerators and other white goods. These programs seek to replace large appliances that are old and inefficient or faulty by newer, more energy-efficient appliances, to reduce the cost imposed on lower-income families, and reduce pollution caused by the older appliances.
==== S ==== Salami – cured sausage, fermented and air-dried meat, originating from one or a variety of animals. Historically, salami was popular among Southern European peasants because it can be stored at room temperature for periods of up to 30–40 days once cut, supplementing a possibly meager or inconsistent supply of fresh meat. Varieties of salami are traditionally made across Europe. Salumi – Italian cured meat products that are predominantly made from pork. It comes from the Italian word salume, pl. salumi "salted meat", derived from Latin sal "salt". The term salumi also encompasses bresaola, which is made from beef, and also cooked products such as mortadella and prosciutto cotto. Secca de bœuf – a type of dried salted beef made in Entrevaux. Similar to the Swiss Bindenfleisch, it is typically eaten as a starter. Skerpikjøt – a type of wind-dried mutton, is a delicacy of the Faroe Islands which is traditionally eaten at Christmas but also at other times of the year. Slinzega – a type of air-dried meat produced in Valtellina, in the Italian Alps. It is made in a similar manner to Bresaola, with smaller pieces of meat, which therefore bear a stronger taste. Smithfield ham – a specific form of the country ham, A 1926 Statute of Virginia (passed by the Virginia General Assembly) first regulated the usage of the term "Smithfield Ham".
Sources: en.wikipedia.org
The lyophilized powder is generally stored at -20 °C or lower, desiccated, and protected from light. Solutions are often aliquoted to avoid repeated freeze-thaw cycles. Specific stability data may vary by formulation and purity.
Mass spectrometry is commonly used to confirm molecular mass, while RP-HPLC estimates purity. These methods can be combined with amino acid analysis or NMR for further structural confirmation. A certificate of analysis alone does not guarantee independent verification.
Legality depends on the country and the intended use. In many places it is not approved as a drug and may be regulated as a research chemical. Buyers should check local laws and institutional policies before obtaining it.
Dihexa is a synthetic peptide-like compound studied in preclinical research. It is often described as an angiotensin IV analog, but it is not an approved medicine. Public information comes mainly from laboratory work and commercial listings.